1. Signaling Pathways
  2. Others
  3. Drug Intermediate

Drug Intermediate

Drug Iintermediate

Drug intermediates are used as raw materials for the production of bulk drugs, or they can refer to a material produced during synthesis of an API that must undergo further molecular change or processing before it becomes an API. Drug intermediates are hygienically formulated using high grade raw materials and they are used in the pharmaceutical and cosmetic industry[1][2].

Drug Intermediate Related Products (4366):

Cat. No. Product Name Effect Purity Chemical Structure
  • HY-W585820
    4,4′-(Diazoamino)dibenzenesulfonic acid disodium
    99.85%
    4,4′-(Diazoamino) dibenzenesulfonic acid disodium is a chemical compound known for its presence in certain color additives.
    4,4′-(Diazoamino)dibenzenesulfonic acid disodium
  • HY-W016234
    Nimesulide impurity 4
    Nimesulide impurity 4 (Aminodiphenylether) is an impurity of Nimesulide.
    Nimesulide impurity 4
  • HY-W121884
    Fenclofenac glucuronide
    Fenclofenac glucuronide is the major urinary metabolite of Fenclofenac (HY-114806) in horses. Fenclofenac glucuronide undergoes intramolecular structural rearrangement to form a β-glucuronidase-resistant isomer, and releases Fenclofenac via complete alkaline hydrolysis.
    Fenclofenac glucuronide
  • HY-W106109
    2-Hydroxy-4-methylquinoline
    2-Hydroxy-4-methylquinoline is a synthetic intermediate. 2-Hydroxy-4-methylquinoline is formed via cyclization of acetoacetanilide under the action of concentrated sulfuric acid through the Conrad-Limpach-Knorr synthesis. 2-Hydroxy-4-methylquinoline can be used in studies related to the synthesis of chemotherapeutic agents.
    2-Hydroxy-4-methylquinoline
  • HY-78931F
    (R,S,S,S,R)-Boc-Dap-NE
    99.56%
    (R,S,S,S,R)-Boc-Dap-NE is an isomer of the dipeptide Boc-Dap-NE (HY-78931). Boc-Dap-NE is an intermediate in the synthesis of Monomethyl auristatin E (HY-15162), which is an inhibitor of tubulin polymerization. Monomethyl auristatin E can be used to synthesize Antibody-Drug Conjugates (ADCs) as ADC Cytotoxin.
    (R,S,S,S,R)-Boc-Dap-NE
  • HY-117544
    Porphyrin precursor
    Porphyrin precursor is the precursor of Porphyrin for the synthesis of Porphyrin. Porphyrin is a large organic compound containing four modified pyrrole subunits interconnected to each other.
    Porphyrin precursor
  • HY-Z2623
    Apixaban impurity 20
    Apixaban impurity 20 is an impurity of Apixaban.
    Apixaban impurity 20
  • HY-W706169
    Telmisartan impurity 4
    Telmisartan impurity 4 is an impurity of Telmisartan.
    Telmisartan impurity 4
  • HY-78931B
    (S,S,S,S,R)-Boc-Dap-NE
    99.80%
    (S,S,S,S,R)-Boc-Dap-NE is the inactive isomer of Boc-Dap-NE (HY-78931), and can be used as an experimental control. Boc-Dap-NE, is an intermediate in the synthesis of Monomethyl auristatin E (HY-15162), which is an inhibitor of tubulin polymerization. Monomethyl auristatin E can be used to synthesize Antibody-Drug Conjugates (ADCs) as ADC Cytotoxin.
    (S,S,S,S,R)-Boc-Dap-NE
  • HY-Z3978
    Ibrutinib impurity 28
    98.99%
    Ibrutinib Impurity 28 is an impurity of Ibrutinib (HY-10997).
    Ibrutinib impurity 28
  • HY-Z4508
    Montelukast impurity 3
    98.09%
    Montelukast impurity 3 is an impurity of Montelukast.
    Montelukast impurity 3
  • HY-Z3869
    Amoxicillin impurity 7
    Amoxicillin Impurity 7 is an impurity of Amoxicillin (HY-B0467A).
    Amoxicillin impurity 7
  • HY-W071559
    6-(2,2,2-Trifluoroethyl)thieno[2,3-d]pyrimidin-4(1H)-one
    6-(2,2,2-Trifluoroethyl)thieno[2,3-d]pyrimidin-4(1H)-one is a drug intermediate for synthesis of various active compounds.
    6-(2,2,2-Trifluoroethyl)thieno[2,3-d]pyrimidin-4(1H)-one
  • HY-75923
    2,2-Dimethyl-1-(2-thioxothiazolidin-3-yl)propan-1-one
    2,2-Dimethyl-1-(2-thioxothiazolidin-3-yl)propan-1-one is a drug intermediate for synthesis of various active compounds.
    2,2-Dimethyl-1-(2-thioxothiazolidin-3-yl)propan-1-one
  • HY-W057459
    (R)-3-Oxo-cyclopentanecarboxylic acid methyl ester
    (R)-3-Oxo-cyclopentanecarboxylic acid methyl ester is a synthetic intermediate useful for pharmaceutical synthesis.
    (R)-3-Oxo-cyclopentanecarboxylic acid methyl ester
  • HY-W267824
    Aripiprazole impurity 23
    Aripiprazole impurity 23 is an impurity of Aripiprazole.
    Aripiprazole impurity 23
  • HY-W883657
    Lamivudine impurity 4
    Lamivudine impurity 4 is an impurity of Lamivudine.
    Lamivudine impurity 4
  • HY-W004079
    Bupropion impurity 13
    Bupropion impurity 13 is an impurity of Bupropion.
    Bupropion impurity 13
  • HY-W048402
    Neratinib impurity 11
    Neratinib impurity 11 is an impurity of Neratinib (HY-32721).
    Neratinib impurity 11
  • HY-Z6535
    Lidocaine impurity 12
    99.54%
    Lidocaine impurity 12 is an impurity of Lidocaine (HY-B0185).
    Lidocaine impurity 12